Inflammatory Bowel Diseases

Cover image for Vol. 13 Issue 11

November 2007

Volume 13, Issue 11

Pages 1323–1455

  1. Original Basic Science Articles

    1. Top of page
    2. Original Basic Science Articles
    3. Original Clinical Articles
    4. Editorial
    5. Basic Science Review
    6. Clinical Review
    7. Pediatric Review
    8. Current Controversies–Pro
    9. Current Controversies–Con
    10. Current Controversies–Balance
    11. Selected Summaries
    12. Letters to the Editor
    1. Mechanism of action of certolizumab pegol (CDP870): In vitro comparison with other anti-tumor necrosis factor α agents (pages 1323–1332)

      Andrew Nesbitt, Gianluca Fossati, Marianne Bergin, Paul Stephens, Sue Stephens, Roly Foulkes, Derek Brown, Martyn Robinson and Tim Bourne

      Version of Record online: 16 JUL 2007 | DOI: 10.1002/ibd.20225

    2. TNFSF15 is an ethnic-specific IBD gene (pages 1333–1338)

      Yoana Picornell, Ling Mei, Kent Taylor, Huiying Yang, Stephan R. Targan and Jerome I. Rotter

      Version of Record online: 30 JUL 2007 | DOI: 10.1002/ibd.20223

    3. Mesenteric adipose tissue alterations resulting from experimental reactivated colitis (pages 1357–1364)

      Alessandra Gambero, Marta Maróstica, Mario José Abdalla Saad and José Pedrazzoli Jr.

      Version of Record online: 29 JUN 2007 | DOI: 10.1002/ibd.20222

  2. Original Clinical Articles

    1. Top of page
    2. Original Basic Science Articles
    3. Original Clinical Articles
    4. Editorial
    5. Basic Science Review
    6. Clinical Review
    7. Pediatric Review
    8. Current Controversies–Pro
    9. Current Controversies–Con
    10. Current Controversies–Balance
    11. Selected Summaries
    12. Letters to the Editor
    1. Exacerbation of ulcerative colitis after rituximab salvage therapy (pages 1365–1368)

      Martin Goetz, Raja Atreya, Maryam Ghalibafian, Peter R. Galle and Markus F. Neurath

      Version of Record online: 29 JUN 2007 | DOI: 10.1002/ibd.20215

    2. Long-term clinical results of ileocecal resection for Crohn's disease (pages 1369–1373)

      Garret Cullen, Aoibhlinn O'Toole, Denise Keegan, Kieran Sheahan, John M. Hyland and Diarmuid P. O'Donoghue

      Version of Record online: 28 JUN 2007 | DOI: 10.1002/ibd.20220

    3. Fecal M2-pyruvate kinase (M2-PK): A novel marker of intestinal inflammation (pages 1374–1378)

      Guy Chung-Faye, Bu'Hussain Hayee, Susan Maestranzi, Nora Donaldson, Ian Forgacs and Roy Sherwood

      Version of Record online: 18 JUN 2007 | DOI: 10.1002/ibd.20214

    4. Changes of OPG and RANKL concentrations in Crohn's disease after infliximab therapy (pages 1379–1384)

      Pál Miheller, Györgyi Műzes, Károly Rácz, Anna Blázovits, Péter Lakatos, László Herszényi and Zsolt Tulassay

      Version of Record online: 30 JUL 2007 | DOI: 10.1002/ibd.20234

    5. Preterm birth but not mode of delivery is associated with an increased risk of developing inflammatory bowel disease later in life (pages 1385–1390)

      Barbara Sonntag, Birgit Stolze, Achim Heinecke, Andreas Luegering, Jan Heidemann, Pia Lebiedz, Emile Rijcken, Ludwig Kiesel, Wolfram Domschke, Torsten Kucharzik and Christian Maaser

      Version of Record online: 13 JUN 2007 | DOI: 10.1002/ibd.20206

    6. Sustained improvement of health-related quality of life in Crohn's disease patients treated with infliximab and azathioprine for 4 years (pages 1395–1400)

      Francesc Casellas, Luis Rodrigo, Pilar Niño, Carmen Pantiga, Sabino Riestra and Juan-Ramon Malagelada

      Version of Record online: 13 JUN 2007 | DOI: 10.1002/ibd.20205

    7. Population-based analysis of practices and costs of surveillance for colonic dysplasia in patients with primary sclerosing cholangitis and colitis (pages 1401–1407)

      Gilaad G. Kaplan, Steven J. Heitman, Robert J. Hilsden, Stefan Urbanski, Robert P. Myers, Samuel S. Lee, Kelly W. Burak, Mark Swain and Remo Panaccione

      Version of Record online: 28 JUN 2007 | DOI: 10.1002/ibd.20204

    8. Race and health insurance are predictors of hospitalized Crohn's disease patients undergoing bowel resection (pages 1408–1416)

      Geoffrey C. Nguyen, Theodore M. Bayless, Neil R. Powe, Thomas A. LaVeist and Steven R. Brant

      Version of Record online: 13 JUN 2007 | DOI: 10.1002/ibd.20200

  3. Editorial

    1. Top of page
    2. Original Basic Science Articles
    3. Original Clinical Articles
    4. Editorial
    5. Basic Science Review
    6. Clinical Review
    7. Pediatric Review
    8. Current Controversies–Pro
    9. Current Controversies–Con
    10. Current Controversies–Balance
    11. Selected Summaries
    12. Letters to the Editor
  4. Basic Science Review

    1. Top of page
    2. Original Basic Science Articles
    3. Original Clinical Articles
    4. Editorial
    5. Basic Science Review
    6. Clinical Review
    7. Pediatric Review
    8. Current Controversies–Pro
    9. Current Controversies–Con
    10. Current Controversies–Balance
    11. Selected Summaries
    12. Letters to the Editor
    1. New players in the cytokine orchestra of inflammatory bowel disease (pages 1419–1423)

      Massimo C. Fantini, Giovanni Monteleone and Thomas T. MacDonald

      Version of Record online: 21 AUG 2007 | DOI: 10.1002/ibd.20212

  5. Clinical Review

    1. Top of page
    2. Original Basic Science Articles
    3. Original Clinical Articles
    4. Editorial
    5. Basic Science Review
    6. Clinical Review
    7. Pediatric Review
    8. Current Controversies–Pro
    9. Current Controversies–Con
    10. Current Controversies–Balance
    11. Selected Summaries
    12. Letters to the Editor
  6. Pediatric Review

    1. Top of page
    2. Original Basic Science Articles
    3. Original Clinical Articles
    4. Editorial
    5. Basic Science Review
    6. Clinical Review
    7. Pediatric Review
    8. Current Controversies–Pro
    9. Current Controversies–Con
    10. Current Controversies–Balance
    11. Selected Summaries
    12. Letters to the Editor
    1. Pediatric inflammatory bowel disease: Clinical and molecular genetics (pages 1430–1438)

      Vincent Biank, Ulrich Broeckel and Subra Kugathasan

      Version of Record online: 28 JUN 2007 | DOI: 10.1002/ibd.20213

  7. Current Controversies–Pro

    1. Top of page
    2. Original Basic Science Articles
    3. Original Clinical Articles
    4. Editorial
    5. Basic Science Review
    6. Clinical Review
    7. Pediatric Review
    8. Current Controversies–Pro
    9. Current Controversies–Con
    10. Current Controversies–Balance
    11. Selected Summaries
    12. Letters to the Editor
  8. Current Controversies–Con

    1. Top of page
    2. Original Basic Science Articles
    3. Original Clinical Articles
    4. Editorial
    5. Basic Science Review
    6. Clinical Review
    7. Pediatric Review
    8. Current Controversies–Pro
    9. Current Controversies–Con
    10. Current Controversies–Balance
    11. Selected Summaries
    12. Letters to the Editor
  9. Current Controversies–Balance

    1. Top of page
    2. Original Basic Science Articles
    3. Original Clinical Articles
    4. Editorial
    5. Basic Science Review
    6. Clinical Review
    7. Pediatric Review
    8. Current Controversies–Pro
    9. Current Controversies–Con
    10. Current Controversies–Balance
    11. Selected Summaries
    12. Letters to the Editor
  10. Selected Summaries

    1. Top of page
    2. Original Basic Science Articles
    3. Original Clinical Articles
    4. Editorial
    5. Basic Science Review
    6. Clinical Review
    7. Pediatric Review
    8. Current Controversies–Pro
    9. Current Controversies–Con
    10. Current Controversies–Balance
    11. Selected Summaries
    12. Letters to the Editor
  11. Letters to the Editor

    1. Top of page
    2. Original Basic Science Articles
    3. Original Clinical Articles
    4. Editorial
    5. Basic Science Review
    6. Clinical Review
    7. Pediatric Review
    8. Current Controversies–Pro
    9. Current Controversies–Con
    10. Current Controversies–Balance
    11. Selected Summaries
    12. Letters to the Editor
    1. Tuberculin test in patients with inflammatory bowel disease (page 1451)

      John K. Triantafillidis, Filippos Georgopoulos, George Malgarinos and Aristofanis Gikas

      Version of Record online: 13 JUN 2007 | DOI: 10.1002/ibd.20207

    2. Infliximab: An alternative treatment for refractory immune thrombocytopenic purpura related to Crohn's disease? (pages 1452–1453)

      Georgia Lazaraki, Simeon Metallidis, Kleanthis Giannoulis, Anestis Tarpagos and Georgios Germanidis

      Version of Record online: 18 JUN 2007 | DOI: 10.1002/ibd.20209

    3. Cluster of Crohn's disease in Herny, France, including 2 cases from a common residence (pages 1454–1455)

      Herbert J. Van Kruiningen, Marie Joossens and Jean-Frédéric Colombel

      Version of Record online: 28 JUN 2007 | DOI: 10.1002/ibd.20217

SEARCH

SEARCH BY CITATION